JLE

Hépato-Gastro & Oncologie Digestive

MENU

Liver and muscular diseases Volume 26, issue 1, Janvier 2019

  • [1] McMillan HJ, Gregas M, Darras BT, Kang PB. Serum transaminase levels in boys with duchenne and becker muscular dystrophy. Pediatrics 2011 ; 127 (1) : e132-6.
  • [2] Wroblewski F. The clinical significance of transaminase activities of serum. Am J Med. 1959;27:911-923.
  • [3] Etienne E, Hanser A-M, Woehl-Kremer B, Mohseni-Zadeh M, Blaison G, Martinot M. Macroenzymes: macro-ASAT et macro-CPK. Deux observations et revue de la littérature. /data/revues/02488663/v30i11/S0248866309006596/[Internet]. 2009 Nov 2 [cited 2018 Jul 12] ; Available from : http://www.em-consulte.com/en/article/230527.
  • [4] Tsung S.H. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin Chem. 1976;22:173-175. 2
  • [5] Wu H.-J., Chen K.-T., Shee B.-W., Chang H.-C., Huang Y.-J., Yang R.-S. Effects of 24 h ultra-marathon on biochemical and hematological parameters. World J Gastroenterol WJG. 2004;10:2711-2714. 18
  • [6] Cervellin G, Comelli I, Benatti M, Sanchis-Gomar F, Bassi A, Lippi G. Non-traumatic rhabdomyolysis : Background, laboratory features, and acute clinical management. Clin Biochem 2017 ; 50 (12) : 656-62.
  • [7] Hoffman EP, Brown RH, Kunkel LM. Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell 1987 ; 51 (6) : 919-28.
  • [8] Ryder S, Leadley RM, Armstrong N, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: An evidence review. OrphanetJ Rare Dis 2017 ; 12 : 79.
  • [9] Turner C, Hilton-Jones D. Myotonic dystrophy: Diagnosis, management and new therapies. Curr Opin Neurol 2014 ; 27 (5) : 599-606.
  • [10] Klein A.F., Gasnier E., Furling D. Gain of RNA function in pathological cases: Focus on myotonic dystrophy. Biochimie. 2011;93:2006-2012. 11
  • [11] Poynard T., Bedossa P., Naveau S., Lemaigre G., Martin E.D., Chaput J.-C. Perisinusoidal cells (Ito-cells) enlargement in a family with myotonic dystrophy. Liver. 1989;9:276-278. 5
  • [12] Heatwole C.R., Miller J., Martens B., Moxley R.T. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol. 2006;63:1149-1153. 8
  • [13] Shieh K, Gilchrist JM, Promrat K. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. Muscle Nerve 2010 ; 41 (2) : 197-201.
  • [14] Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967. 5
  • [15] Moxley RT, Kingston WJ, Griggs RC, Livingston JN. Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy. Diabetes 1987 ; 36 (6) : 693-701.
  • [16] Wheeler T.M., Thornton C.A. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol. 2007;20:572-576. 5
  • [17] Cloots K, Verbeek J, Orlent H, Meersseman W, Cassiman D. Mitochondrial hepatopathy in adults: a case series and review of the literature. Eur J Gastroenterol Hepatol 2013 ; 25 (8) : 892-8.
  • [18] El-Hattab AW, Scaglia F. Mitochondrial cytopathies. Cell Calcium 2016 ; 60 (3) : 199-206.
  • [19] Lee W.S., Sokol R.J. Liver Disease in mitochondrial disorders. Semin Liver Dis. 2007;27:259-273. 03
  • [20] Milone M., Wong L.-J. Diagnosis of mitochondrial myopathies. Mol Genet Metab. 2013;110:35-41. 1
  • [21] Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: Clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 2010 ; 33 (5) : 527-32.
  • [22] De Biase I., Viau K.S., Liu A. Diagnosis, treatment, and clinical outcome of patients with mitochondrial trifunctional protein/long-chain 3-hydroxy acyl-coa dehydrogenase deficiency. JIMD Rep. 2016;28:63-71. 31
  • [23] Tarnopolsky M, Katzberg H, Petrof BJ, et al. Pompe disease: Diagnosis and management. Evidence-based guidelines from a canadian expert panel. Can J Neurol Sci 2016 ; 43 (4) : 472-85.
  • [24] Konikoff F., Theodor E. Painful muscle cramps. A symptom of liver cirrhosis? J Clin Gastroenterol. 1986;8:669-672. 6
  • [25] Vidot H., Carey S., Allman-Farinelli M., Shackel N. Systematic review: the treatment of muscle cramps in patients with cirrhosis. Aliment Pharmacol Ther. 2014;40:221-232. 3